从上皮组织细胞变化分析肺与大肠相表里的内涵
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
“肺与大肠相表里”是中医基础理论之一,对指导临床实践有重要价值。从《黄帝内经》至近代医家的多种论著中,不论是经络学说还是脏腑学说,对肺与大肠表里关系均有不同程度的认识。随着免疫学、分子生物学和细胞生物学的发展,人们对“肺与大肠相表里”的中医理论认识也日趋深入,不仅在实验研究上取得了一定成就,而且在临床运用中也更加广泛。
     1.研究目的:
     本文旨在从中医学文献研究探讨“肺合大肠”理论基础,并通过人体胚胎实验研究从微观层次分析认识肺与大肠及其相互联系,以期为肺与大肠相关性理论及实验研究提供更新的支持,丰富“肺与大肠相表里”理论的基本内涵,并为中医藏象学说和中医基础理论的现代研究提供新的思路和方法。
     2.研究方法:
     2.1理论探讨:
     理论研究中利用古今文献,分析并阐释了肺与大肠表里关系的理论意义。说明组织胚胎研究在中医脏腑表里关系和脏腑实质研究中的意义,进一步充实了中医脏腑理论内涵。
     2.2实验研究:
     紧紧围绕脏腑“组织发生”和“相关性”,以人胚胎为实验材料,从现代组织胚胎学、免疫学、细胞生物学出发,采用细胞生物、免疫组化、蛋白免疫印迹等实验技术。本研究对脏腑物质实质探讨较多,并涉及到胚胎器官的一些初级生理机能。因此,可作为成体脏器“肺”与“大肠”功能相关研究的有益和必要的补充。
     3.研究结果:
     3.1理论研究结果:
     肺与大肠的表里关系是脏腑表里关系的重要内容之一,肺与大肠通过经络的联系,构成了脏腑阴阳表里两经的络属关系;在生理功能上紧密联系,病变上也相互影响。“肺与大肠相表里”中的“大肠”可以认为是“回肠、结肠”这个结论与《黄帝内经》中“大肠”论述相符。肺、肠的上皮组织均来源于原肠胚之内胚层,同时上皮组织及细胞又是二者的最主要功能单位。研究上皮组织及细胞的发生发育过程,在肺肠表里关系的实验中医学研究中具有重要的意义。
     3.2实验研究结果:
     3.2.1胚胎发育不同时期肺与肠上皮组织形态学特征(HE)及上皮细胞增殖、凋亡的生物学特性比较分析:胚胎早期(9-16周胎龄),肺与全肠在上皮组织及细胞形态一致,上皮细胞增殖、凋亡的生物学特性无显著差异(P>0.05)。胚胎中期(17~23周)、胚胎晚期(24周~出生)肺与全肠在上皮组织及细胞形态不一致,上皮细胞增殖、凋亡的生物学特性有显著差异性(P<0.05)。
     3.2.2组织细胞活性蛋白物质T淋巴细胞亚群(CD3+、CD4+、CD8+),表面活性物质相关蛋白A (SPA)、蛋白酶激活受体(PARS)、水通道蛋白(AQP1)观察显示:胚胎各期“肺”与“回肠、结肠”无显著差异(P>0.05),而与“空肠、直肠、膀胱”存在显著差异(P<0.05)。
     4.研究结论:
     4.1肺与回肠、结肠在胚胎发育过程中,无论从上皮组织的增殖凋亡,还是组织细胞活性蛋白物质的表达上均存在发生时相上的同步性。
     4.2“肺与大肠相表里”中的“大肠”应定位于“回肠、结肠”。
     4.3在胚胎早期可以为“肺”与“回肠、结肠”同源发生提供一定的依据,“肺与大肠相表里”肺肠相关虽主要是功能之间的相互联属,但可能与其原始的同源性相关。
'Lung and large intestine being interior-exteriorly related'is one of the basic theories of traditional Chinese medicine, which have great value in clinical practice. From the'Huang Di's Classic of Internal Medicine'to modern times, many writings of medical scientist, whether viscera or Meridian theory, have different levels of understanding. As immunology, molecular biology and cell biology develop, people have increasingly in-depth theoretical knowledge of "lung and large intestine"not only in the experimental study but also in the clinicaluse of more wide.
     1. Objective:
     This article aims to study the theoretical basis from the medical literature, analyze of lung, colon and their interlinkages from the micro-level by experimental, To provide up-to-date support for the theory of'lung and large intestine being interior-exteriorly related rich the basic content of the theory, and provide new ideas and methods for state of viscera and theory of the basic theory of traditional Chinese medicine.
     2.Methods:
     2.1 Theoretical Discussion:
     This study adopting documentation and logical analysis explored significance of epithelium of embryonic lung and Intestinal relations at all levels, clarified significance of embryology in'fu-zang being interior-exteriorly related'and the actual situation of viscera, further enrich the content of theory of visceral outward manifestation of traditional Chinese medicine.
     2.2 Experimental Study:
     Selected gestational age 9-16 weeks, cases of voluntary termination of pregnancy by induced labor abortion or induction of labor with water bag,put embryos aside in 4℃refrigerator. Be divided into three periods by human fetal lung development,namely glandular period(9 to 16 weeks) , small tube of (17-23 weeks) and the original alveolar formation (24 weeks to birth). Each sample has 8 embryos, men and women regardless.
     3.Results:
     3.1 Theory research results:
     3.1.1'The lung and the large intestine being interior-exteriorly related'is one of the best important traditional Chinese medical theories of the Viscera-State doctrine. The lung and the large intestine are interconnected through meridian, which construct the interdependent relationship between yin-yang and interior-exteriorly related viscus; be in close touch with and influence each other whether in normal functioning or in pathological changes.
     3.1.2 Combined with literature of ancient physicians, the'large intestine'in'the lung and the large intestine being interior-exteriorly related'can be considered'ileum and colon'.This conclusion agrees with Huangdi Neijing.
     3.1.3 Histoembryology discovers both the epithelial tissue of lung and large intestine were derived from the gastrula endoderm. At the same time, the epithelial tissue and cell is the primary and the most representative functional units, for this reason, they are be used for focal point of our research. That research development process of epithelial tissue and cell plays an irreplaceable role in the experiment of TCM study.
     3.2 Experimental research results:
     3.2.1 Embryonic development in different periods of lung and intestinal epithelium morphology (HE) and developmental when comparing analysis:
     The Embryonic early-term (9-16 weeks), lung and bowel in epithelial tissue and cell morphology, epithelial biological characteristics, occurs similarity. Embryonic medium-term (17-24 weeks) and late-term(25weeks-) was in the lung and intestinal epithelium and cellular form, epithelial biological characteristics, occurs phase were inconsistent.
     3.2.2 Epithelial tissue active protein material test and observation:
     Each growth phase tissue cell active protein substances observation shows:The Embryonic early-term (9-16 weeks), lung, ileum and colon epithelial tissue active protein substances no significant difference; the jejunum,rectum and bladder exists significant difference. Embryonic medium-term (17-23 weeks) and embryonic late-term (24 weeks-), various intestinal section and bladder are obvious differences.
     4. Conclusions:
     4.1 The embryonic early-term (9-16 weeks), lung, colon and ileum, in epithelial tissue morphology, epithelial characteristics, occurs phase , epithelial tissue active protein substances shows approximation. That may be to lung and most bowel section from the endoderm similar or identical sites and cell source are concerned.
     4.2 In the embryonic medium-term, embryonic late-stage, lung and intestinal epithelium and cellular form, epithelial biological characteristics, occurs phase were inconsistent. Shows them in order to adapt to the formation of their physiological function, the organization forms, and cellular characteristics, activeprotein substances have acorresponding change.
     4.3 Integrate theoretical with experimental research:only in the early embryos may offer limited basis for "lung" and "ileum", "colon" related.As their primary function of middle-late term, material and organizational form in order to adapt to this change appear inconsistent , therefore can not provide the basis. Therefore, discusses'lung and colon exterior-interior relationships' from embryology has limited significance.
引文
[1]杜毅,孟凡红.“肺与大肠相表里”探究,内蒙古中医药,2008,7[12]:51-53.
    [2]王仲霞.“肺与大肠相表里”的理论及临床研究进展,北京中医,2006,25[7]438-440.
    [3]关瑞锋.从肺与大肠相表里谈痰热壅肺型肺心病的辨证施护,牡丹江医学院学报,2003,24(6):49-53.
    [4]王又红.毒素清对大肠杆菌肺炎老龄大鼠肺脏sIgA和FN作用,中国误诊学杂志,2005,5[11]:2049-2051.
    [5]Mccord JM, et al. The superoxide free radical; Its biochemistryand puthophysiology,surgery,1983,94:412~417.
    [6]高国林,李彦敏,安会波.大鼠肠缺血再灌注损伤中Fas表达与肺损伤,中华儿科杂志,2003,41(10):773-776.
    [7]韩国栋,冯学瑞,郝泗城等.大承气汤对实验性肺损害促修复作用的观察,中国医药学报,1994,9(5):15-17.
    [8]杨胜兰,王鹏,李道本.通腑法对大鼠肠源性肺损伤保护作用机制的研究,中国中西医结合消化杂志,2003,11(3):155-157.
    [9]侯静,郁正亚,许媛.肠缺血后肺内一氧化氮合酶的表达及其意义,中华实验外科杂志,2004,21(6):715-718.
    [11]何中乾,蒋健,陆一鸣.氧自由基在大鼠肠缺血再灌流致肺损伤中的作用,同济大学学报(医学版),2002,23(5):368-373.
    [12]韩国栋,常絮化,冯学瑞.对“肺与大肠相表里”理论的实验研究———承气汤对改进动物模型肺脏的影响,中医杂志,1990,(2):48-50.
    [13]哈木拉提·吾甫尔,李风森,艾买江·吐尼亚孜.“肺与大肠相表里”的科学性及其对哮喘治疗的指导意义,新疆医科大学学报,2000,23(2):151-157.
    [14]周东浩,张蕾,周明爱.肺与大肠相表里今释,中国中医基础医学杂志,2003,9(8):567-571.
    [15]杨胜兰,王鹏.大承气汤对肠源性肺损伤大鼠肺组织抗氧化保护作用的研究,湖北中医学院学报,2003,5(3):21-26.
    [16]吴成雁.肃肺通下法治疗开胸术后并发症的体会,中医研究,1996,9(1):37.
    [17]哈木拉提,阿不都艾尼,阿不都热依木等.氧化-抗氧化与哮喘及维吾 尔医“肺肠同治论”关系的研究[J],中国民族医药杂志,2001,6(1):34-36.
    [18]刘福成,薛芳,崔志永等.大承气汤治疗严重创伤呼吸窘迫综合征的实验与临床研究[J],中国中西医结合杂志,1992,12(9):541-545.
    [19]李建生,马利军,李素云,等.毒素清对肺炎老龄大鼠小肠组织自由基和前列腺素代谢的影响,辽宁中医杂志,2003,30(1):3-6.
    [20]匡调元.中医病理研究.上海:上海科学技术出版社,1980:145.
    [21]罗自强,岳少杰.肠缺血再灌注后的肺损伤,国外医学·呼吸系统分册,1994,14(1):251-253。
    [22]KoksoyC,KuzuMA,ErgunH,etal.Intestinalischemia-reperfu-sioni mpairsvasomtor functions of pulmonary vascular bed.AnnSurg,2000 231 (1):105~111.
    [23]薛芳,崔永志,李宏森等.大承气汤治疗家兔呼吸窘迫综合征的研究,中西医结合杂志,1988,8(5):285-287.
    [24]王今达,高无元,崔乃杰等.祖国医学“肺与大肠相表里”学说的临床意义及其本质的探讨,中西医结合杂志,1982,2(2):77-81.
    [25]张余森,彭代国,白朝勇等.“肺与大肠相表里”动物模型的制作及其机理初探,中兽医医药杂志,1987,(2):1-4.
    [26]冯学瑞,宋小棣,刘迪.“肺与大肠相表里”的实验研究,山东中医药大学学报,2006,30(2):170-173.
    [27]韩国栋.“肺与大肠相表里”理论中西医结合研究进展,天津中医,1995,(4):45-47.
    [24]张世林,宇克莉,毕平.肠缺血再灌注大鼠肺损伤时NOS及肺泡巨噬细胞分泌NO的变化,海峡药学,2000,12(2):23-27.
    [25]宇克莉,毕平,李会强.肠缺血再灌注对大鼠肺组织一氧化氮及一氧化氮合酶的影响,天津医科大学学报,2000,6(2):165-171.
    [26]贾君君,陈旭,解秸萍.“肺与大肠相表里”的现代研究概况,中医药学报,2006,34(3):35-37.
    [28]蒋学武,胡廷泽,赖亚曼等.小儿绞窄性肠缺血术后低氧血症的临床及实验研究,中国现代医学杂志,2002,12(15):27-29.
    [29]田在善,沈长虹,李东华等.大承气汤对便秘大鼠肺泡巨噬细胞活力的影响———“肺与大肠相表里”的实验研究,天津中医,1992,(4):19-22.
    [30]李新宇,景炳文,陈德昌等.大黄对大鼠肠缺血再灌注所致肺损伤过程中内源性NO的影响,中国急救医学,1999,19(8):454-456.
    [31]应明英,林英,黄英等.大肠杆菌感染性休克和急性肺损伤大鼠模型的实验研究[J],华西医学,2001,16(4):449-450.
    [32]季幸妹,周福生,侯丽颖.应用蛋白质组学探讨中医,“肺与大肠相表里”理论,中医杂志2008,49[12]:1065-1067.
    [33]曾祥国.从黏液组织化学变化试论肺与大肠的阴阳表里关系,四川医学,1982,3(3):129-132.
    [34]冯有为,林红伍.支气管哮喘患者血浆胃动素及胃泌素水平观察,天津中医,2000,17(2):18-19.
    [35]陈永光.慢性支气管炎虚症患者胃肠功能的X线观察,中国中西医结合杂志,1983,3(4):225-227.
    [36]刘长恩,兰岚.炎症性肠病的肺部表现,中国实用内科杂志,2002,20(7):438-439.
    [37]冯维斌,刘伟胜.通里攻下法在肺心病急性呼吸衰竭的应用,中国中医急症,1998,7(4):180-181.
    [37]严仪昭.内毒素引起的急性肺损伤的实验研究,中华结核及呼吸系统疾病杂志,1985,8(1):7-10.
    [38]翁惠英.慢性阻塞性肺病机械通气患者肠内营养的价值及护理,实用护理杂志,2002,18(5):3-4.
    [38]郑舜华,崔儒涛.补肺方抗实验性溃疡性结肠炎大鼠脂质过氧化损伤的研究,中国中医药科技,1999,6(4):231-234.
    [40]沈洪,朱董萱,刘万里,等.调理脾肺法对实验性大鼠溃疡性结肠炎作用机理的研究,江苏中医药,2002,23(12):53-54.
    [41]陈培琼.从肺肾论治老年性便秘71例,广东医学,1999,20(3):8-10.
    [42]刘小雨.从肺论治顽固性消化溃疡92例,湖南中医药导报,1999,5(3):17-19.
    [43]陈剑屏.宣肺理气治便秘,上海中医药杂志,1996,37(6):41-43.
    [44]魏占美.理肺汤治疗习惯性便秘26例,四川中医,1997,15(10):23-25.
    [45]张小军.慢性肠炎从肺论治,陕西中医,1996,17(7):336-337.
    [46]廖荣鑫.试论“肺病治肠”的理论基础与临床应用,《甘肃中医》2002,16(6):1-3.
    [47]诸惜勤等.清热活血通腑法治疗流行性喘憋型肺炎30例,南京中医学院学报,1989,(4):24-27.
    [48]谢邦军.加味宣白承气汤直肠滴注治疗痰热腑实型肺性脑病20例,中医外治杂志,1997,6(3):16-17.
    [49]张石义.加味已椒苈黄汤治疗支气管哮喘急性发作50例,山东中医学院学报,1995,19(4):235-237.
    [50]林群莲,黄发盛.通腑法治疗肺心病急性发作期,中西医结合杂志,1996,9(10):621-624.
    [51]苏惠萍.通腑法治疗哮喘发作期的临床应用,北京中医药大学学报,1995,18(5):64-67.
    [52]刘刚.通因通用法治疗重症肺气肿,四川中医,1995,13(6):23-27.
    [53]张元兵.“肺与大肠相表里”理论在慢性阻塞性肺疾病急性发作期的应用,江西中医药,2000,31(3):15-17.
    [54]关瑞锋.从肺与大肠相表里谈痰热壅肺型肺心病的辨证施护,牡丹江医学院学报,2003,24(6):49-54.
    [55]游文华.谈肺与大肠表里相关的临床体会,新中医,1990,22(3):181-184.
    [1][唐]王冰:《黄帝内经素问》,北京:人民卫生出版社,1956:62-63.
    [2]《中国哲学史资料简编》编委会.《中国哲学史资料简编》,北京:中华书局出版社,1962:245.
    [3]高付斌.中医理论与人体层次结构,第三届国际中医药工程学术会议论文集[C],2006:34-37.
    [4]罗正威,中医五脏实质为三胚层说,中国中医基础医学杂志,2002,8[9]:3-6.
    [5]季幸姝,周福生,侯丽颖.应用蛋白质组学探讨中医“肺与大肠相表里’理论,中医杂志,2008,49[12]:1065-1067.
    [6]陈慰峰.医学免疫学.北京:人民卫生出版社,2000:300.
    [7]Abbus AK, et al.Cellular and molecular immunology.4thed Philadelphia:W. B. Saunders,2000,44[6]:54-56.
    [8]Janeway CA,et al. Immunobiology,4thed. New York:Current Biology Publication,2001,22[1]:184-196.
    [9]罗琦,刘凤斌,廖荣鑫.脾胃湿热证大鼠模型胃粘膜上皮细胞凋亡及相关调控基因(P53、Bcl-2)表达的影响,中华中医药学会脾胃病分会第十九次全国脾胃病学会交流论文集,2006:106-109.
    [10]窦勇鹰,谢立群,李俊美.蛋白酶激活受体-2激动剂在应激性溃疡中的作用,世界华人消化杂志,2006,14[34]:3306-3310.
    [1]王仲霞,刘汶.“肺与大肠相表里”的理论及临床研究进展,北京中医,2006,7(25):438-440.
    [2]Blau H, Riklis S, Kravtsov V, et al.Secretion of cytokines by rat alveolar epithelial cells:possible regulatory role for SP-A. Am J Physiol,1994,266 (2Pt1):L148-151.
    [3]哈尔滨医科大学基础医学院.肠道粘膜免疫的构成与功能,细胞生物学,哈尔滨医科大学网络课程,2007.
    [4]ROTHKOTTER H.More newly formed T than B lymphocytes leave the intestinal mucosavia lymphatics[J],Eur J Immunol,1995,25(3):866-869.
    [5]Dobbie J W. Surfactant protein A and lamellar bodies:a homologous seer etory function of peritoneum, synovium, and lung. Perit Dial Int, 1996,16 (6):574.
    [6]陈冠达.中医肺脏功能的理论及其与脏腑的相关性研究,湖北中医学院,2009年硕士学位论文.
    [7]方亚利.“肺合大肠”理论的发生基础及实验研究,中医基础理论,2005年医学硕士科学学位论文.
    [8]陈永光等.慢性支气管炎中医分型的X线研究(附306例X线分析),福建医药杂志,1981;3(5):1-5.
    [9]颜学涛.“肺与大肠相表里”在慢性肺心病治疗中的运用,湖北中医学院,2009年中医内科学硕士学位论文。
    [10]邓中炎,徐志伟,陈群.中医基础理论体系的现代研究,广东:广东科技出版社,2002:56。
    [11]何权瀛.肺气虚实质的研究概况,中西医结合杂志,1985,5(5):618-620.
    [12]孟雷等.近十年肺气虚实质研究进展,安徽中医学院学报,1992,11(3):60-63.
    [13]陆和屏等.肺气虚动物模型的实验研究,中国病理生理杂志,1996;12(6):62-65.
    [14]陈永光等.慢性支气管炎中医分型的X线研究(附306例X线分析),福建医药杂志,1981,3(5):1-4.
    [15]沈家根等.慢支的中西医结合诊断分型的X线表现,上海中医药杂志,1982:(12):23-24.
    [16]广西中医学院中医理论研究室.肺气虚的实质研究,广西中医药,1981,(4):33-35.
    [17]宋卫东等.肺气虚证患者支气管及肺泡灌洗液中细胞成分的变化,安徽中医学院学报,1993;12(4):12-16.
    [18]宋卫东等.慢性支气管炎皮质醇局部作用与辨证分型关系,中国中西医结合杂志,1994,14(10):134-137.
    [19]宋卫东等.肺泡巨噬细胞内cAMP和cGMP与肺气虚证的关系,中国医药学报,1995,10(1):139-142.
    [20]宋卫东等.慢性支气管炎皮质醇局部作用与辨证分型关系,中国中西医结合杂志,1994,14(10):592-595.
    [21]李世殿.对肺主通调水运的认识,山东中医学院学报,1987,(4):24-27.
    [22]周筑安.内啡肽与呼吸系统,生理科学进展,1982,13(4):310-313.
    [23]冯五金等.胃肠激素与中医证型关系的临床研究,中医杂志,1997,38(5):298-301.
    [24]林昭庚,针灸研讨文专辑,中国医药学院研究中心,台中,1985:35-37.
    [25]林昭庚,针灸学新论,中国医药学院研究中心,台中,1992:68-71.
    [1]王仲霞,刘汶.“肺与大肠相表里”的理论及临床研究进展,北京中医,2006,7(25):438-440.
    [2]肠道粘膜免疫的构成与功能.细胞生物学,哈尔滨医科大学基础医学院,哈尔滨医科大学网络课程,2007年.
    [3]ROTHKOTTER H.More newly formed T than B lymphocytes leave the intestinal mucosa via lymphat ics[J].Eur J Immunol,1995,25(3):866-869.
    [4]艾国平,粟永萍,程天民.肠道粘膜免疫的构成与功能,免疫学杂志,2000,16(4):82-83.
    [5]王晓珍,杨小东.肺表面活性物质相关蛋白与慢性阻塞性肺疾病研究进展,四川医学,2007,28(12):1324-1326。
    [6]郝嘉,肖颖彬.肺表面活性物质相关蛋白A研究进展,第三军医大学学报,1999,21(8):12-14.
    [7]Dobbie J W. Surfactant protein A and lamellar bodies:a homologous seer etory function of peritoneum, synovium, and lung.Perit Dial Int, 1996,16 (6):574.
    [8]Strayer DS, Yang S, Jerng HH. Surfactant protein A-binding proteins.Characterization and structures[J].J Biol Chem,1993, 268(25):18779-18784.
    [9]Hallman M, Merritt T A, Akino T, et al.Surfactant protein A, phosp hatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlatio n with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis,1991,144(6):1376.
    [10]Spragg RG, Smith RM.Pathology of the surfactant system of the maturelung[J].AmJ Respir Crit Care Med,1997,155(2):756~760.
    [11]KremlevSG, PhelpsDS.Surfactant protein A stimulation of inflamma tory cytokines and immunoglobulin production[J]. Am J Physiol, 1994,267 (6Pal):L712-L719.
    [13]Bourbon JR,Chailley-HeuB,Sur factant proteins in the digestive tract, mesentery, and other organs:evolutionary significance[J].Comp Biochem Physiol A,2002,129(1):151.
    [14]kuroki Y, Mas on R, J, Voelker D R, et al. Pulmonary sur factant apopro2tein a structure and modulation of sur factant secretion by rat alveolar type Ⅱ cells [J]. J Bio Chem,1988,263 (7):3388-3394.
    [15]Rubio, S, Chailley 2Heu B, Ducroc R et al.Antibody against pulmonarysur factant A recognizes proteins in intestine and swim bladder of thef reshwater fish, carp[J].Bioc Biop Res Comm,1996,225 (3):901-906.
    [16]Eliakim R, Becich N, G reen K, et al. Developmental expression of in2testinal sur factant2like particles in rats[J]. Am J Physiol, 1991,261(24):G269-G279.
    [17]DAgostino B, Roviezzo F, De Palma R, et al. Activation of prote-a se-activated receptor-2 reduces airways inflammation in experimen— ta lallergic asthma[J]Clin ExpAllergy,2007,37(10):1436-1443.
    [18]SekiguchiF,Hasegawa N, Inoshita K, etal Mechanisms f.rmodulatio n of mouse gastrointestinal motility by proteinase-ac—ivated recepto r (PAR)-land-2 in vitro. Life Sci,2006,7(10):950-957.
    [19]Zhao A, Shea-Donohue T. PAR-2 agonists induce contraction of muri ne small intestine through neurokinin receptors. Am J Physiol Gastro int est Liver Physiol,2003,28 (5):696-703.
    [20]Mule F, Baffi MC, Cerra MC. Dual effect mediated by protease-acti vated receptors on the mechanical activity of rat colon.
    [21]程波,蒋静.水通道蛋白亚型AQP1的研究进展程,实用医学杂志,2008,24(2):317-318.
    [22]冯璟,王俊平.水通道蛋白在消化系统表达与调节的研究进展,医学综述,2007,13(17):1295-1296.
    [23]陈淑靖,王桂芳.水通道蛋白1在肺部的研究进展,复旦学报,2007,34(3):469-471.
    [1]陈钥,杜江,封志纯.不同胎龄人胚肺支气管肺泡灌洗液表面活性物质蛋白A-D的变化,实用儿科杂志,2005,20[10]:978-980.
    [3]邓锦波,程建华.人胚胎肺发生的光镜和电镜观察,江西医学院学报1993.33(2):13-17.
    [4]刘斌,高英茂.人体胚胎学,北京:人民卫生出版社,1995:272.
    [5]曾小川,汪维伟.小鼠胚胎十二指肠上皮的体视学研究,世界华人消化杂志,2000,8(5):542-545.
    [6]邓锦波,程建华.人胚胎肺发生的光镜和电镜观察,江西医学院学报,1993,33(2):13-17.
    [7]成军.程序性细胞死亡与疾病.北京:北京医科大学中国协和医科大学联合出版社,1997:9.
    [8]Crisera CA,Maldonado TS,Longaker MT, et al. Defective fibrob-last growth factor signaling allows for nonbranching growth of the respiratory derived fistula tract in esophageal atresia with t racheoe-sophageal fistula. J Pediat r Surg,2000,35 (10):1421-1425.
    [1]杨贵波,邵一鸣.粘膜免疫与艾滋病的预防和控制,中国艾滋病性,2006,12[5]:472-475.
    [2]牛建章,张丽华,朱宝成.粘膜免疫与疫苗,中华现代中西医杂志,2004,2[6]:25-28.
    [3]白雪源.粘膜免疫进展,国外医学-免疫学分册,1999,22[5]:15-18.
    [4]Organ PL, Mistake J lame Meet al.Mucosal Immunology [M].2nd dace demit Press. Boston.1999.
    [5]TakahashiS,KawamuraT,YasuhiroK et al.Multipotential acceptance of Payer's patches in the intestine for both thymus-derived T cells and ex-trathymic T ells in mice[J]. Immunology and Cell Biology,2005; 83:504-510.
    [6]Heel K A, McCauley R D, Papadimitriou J M et al. Review:Peyer' s patches[J]J Gastroenterology Hepatol,1997; 12:122-136.
    [7]Chin Konica S, Yuji M et al. Differentiation of epithelial cellto M cell in response to bacterial colonization on the follicle-associated epithelium of Payer's patch in rat small intestine [J]. J Vet Med Sci, 2006; 68(10):1023-1028.
    [1]Sekiguchi F, Hasegawa N, Inoshita K, et al. Mechanisms for modulation of mouse gastrointestinal motility by protein-ase-act iva ted receptor (PAR)-1 and-2 invitro, Life Sci,2006,78:950-957.
    [2]Zhao A, Shea-Donohue T. PAR-2 agonists induce contraction of murine small intestine through neurokin in receptors. Am J Physiol Gastrointest Liver Physiol,2003,285:G696-703.
    [3]Mule F, Raffi MC. Cerra MC. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br J Pharmacol,2002,136:367-374.
    [4]Kawabata A, Kuroda R, Nagata N, et al. In vivo evidence that protease-activated receptorsl and2 modulate gastrointestinalt ransit in the mouse. Br Jo Pharmacol,2001,133:1213-1218.
    [5]Sato K, Ninomiya H, Ohkura S, et al. Impairment of PAR-2 mediated relaxation system in colonic smooth muscle after intestinal inflammation. Br J Pharmacol,2006,148:200-207.
    [1]唐顺广,倪松石.水通道蛋白与支气管哮喘,临床肺科杂志,2009,6[14]:793-795.
    [2]陈侠,黄中新.胎儿发育中水通道蛋白的免疫组化观察,解剖学研究,29[6]:425-429.
    [3]Bourbon JR, Chailley-Heu B, Sur fa and outcome in small premature infants. Am Rev Respir Dis,2009,8(6):13.
    [4]Hallman M, Merritt T A, Akino T, et al. Surfactant protein A, phosp hatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlatio n with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis,2009,144(6):1376.
    [5]Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respire Crib Care Med,2001,163:1376-1383.
    [6]王锐,刘虹.乌司他丁对急性肺损伤水通道蛋白调节机制的研究,中国药物与临床,2009,4[9]:315-317.
    [1]kuroki Y, Mas on R, J, Voelker D R, et al. Pulmonary sur factant apopro2tein a structure and modulation of sur factant secretion by rat alveolar type Ⅱ cells [J]. J Bio Chem,1988,263 (7):3388-3394.
    [2]RubioS, Chailley 2Heu B, Ducroc R et al. Antibody against pulmonary factant A recognizes proteins in intestine and swim bladder of thefreshwater fish, carp[J]. Bioc Biop Res Comm,1996,225 (3):901-906.
    [3]Eliakim R, Becich N, G reen K, et al. Developmental expression of in2testinal sur factant2like particles in rats [J]. Am J Physiol, 1991,261 (24):G269-G279.